Several of US based investors I am in close contact with understand this tech very well and are ready to position once US funding arrangements will be shared on achievements of milestones this year prior to clinical studies. These investors have joined, are about to join in a material way ( similar to myself ) on the heels of certain board member additions in the US.
A rerate of this stock is about to happen within that time frame.
Market games are clearly on show to attract sellers but will only work that long.
For biotech timelines, this is all around the corner, speaking weeks and months instead of years.
The money on the sidelines committed should see this stock triple in a matter of weeks once that appreciation starts.
Leaning back and wait for developments while digesting failures of competitors in the industry to strengthen our case only further is a nice way to be in a top heavy market which will favour biotech in a correction.
all IMO
PYC Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)